Thereupon, clarifying the GOF activity of each mut-p53 and its underlying impacts on lung cancer progression and prognosis in the context of a specific mutation site, may contribute to achieving a more precise monitoring and management of lung cancer. Here, TP53 is linked to lung carcinoma.